Add to a list

Inactive Instrument

Carmat Stock Other OTC

FR0010907956

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Analysts' recommendations: Carmat

25-05-09	Carmat: Invest Securities raises target price
25-04-11	Carmat: Invest Securities still a buyer, but cuts TP
25-02-04	Carmat: Invest Securities slightly lowers its target
25-01-09	Carmat: Invest Securities upgrades to buy
25-01-09	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat

Mar. 04	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
Jan. 07	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
Jan. 07	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
Jan. 07	CARMAT : A suivre aujourd'hui
Jan. 07	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	2016-08-31
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	2018-12-11
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	2025-03-31

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	2017-01-01
Michael Mack BRD	Director/Board Member	79	2017-04-19

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

As early as today, start finding the best investment opportunities!

Maximize my profits

Market Cap	6.15M 6.92M 5.74M 5.23M 9.86M 665M 9.95M 69.42M 26.9M 340M 25.97M 25.41M 1.09B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 66.68M 55.3M 50.4M 95.06M 6.41B 95.94M 669M 259M 3.28B 250M 245M 10.52B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

Sep. 01	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
Jan. 07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
Jan. 07	CARMAT: To Watch Today
Jan. 06	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
Jan. 06	Carmat Announces Liquidation and Delisting
Dec. 02	Only Takeover Bid for Carmat Approved by Court
Dec. 02	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
Dec. 02	Carmat receives takeover bid	RE
Nov. 04	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
25-10-15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
25-10-15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
25-10-15	Carmat says liquidation review postponed until Nov 25	RE
25-10-01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE

Dec. 02	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
Nov. 04	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
25-10-29	CARMAT : Inside Information / Other news releases	PU
25-10-29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
25-10-15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-.--%	-.--%	-	-	7.08M
ABBOTT LABORATORIES	+0.84%	-3.74%	-27.56%	+1.79%	169B
MEDTRONIC PLC	-0.07%	-2.55%	-11.59%	+12.86%	110B
STRYKER CORPORATION	+0.90%	+1.13%	-25.66%	+3.60%	106B
ESSILORLUXOTTICA	-1.24%	-0.76%	-49.50%	-12.08%	73.87B
CENCORA, INC.	-0.24%	+0.69%	+2.08%	+71.44%	58.98B
HOYA CORPORATION	-0.86%	+2.96%	+12.91%	+61.58%	51.28B
BECTON, DICKINSON AND COMPANY	-0.71%	-3.82%	-8.68%	-31.71%	48.16B
IDEXX LABORATORIES, INC.	+0.12%	-0.17%	-17.87%	+21.91%	40.84B
DEXCOM, INC.	-1.01%	-1.45%	+27.31%	-6.14%	32.21B
Average	-0.23%	-0.86%	-10.95%	+13.69%	76.69B
Weighted average by Cap.	+0.03%	-1.30%	-17.07%	+11.23%

	2023	2024
Net sales	3.84M 4.32M 3.58M 3.26M 6.16M 415M 6.21M 43.34M 16.79M 212M 16.21M 15.86M 681M	7.34M 8.27M 6.85M 6.25M 11.78M 795M 11.89M 82.95M 32.14M 406M 31.03M 30.36M 1.3B
Net income	-53.87M -60.63M -50.28M -45.83M -86.43M -5.83B -87.23M -608M -236M -2.98B -228M -223M -9.56B	-51.4M -57.84M -47.97M -43.72M -82.46M -5.56B -83.23M -581M -225M -2.84B -217M -212M -9.12B
Net Debt	49.64M 55.86M 46.33M 42.23M 79.64M 5.37B 80.38M 561M 217M 2.75B 210M 205M 8.81B	53.1M 59.76M 49.56M 45.17M 85.19M 5.75B 85.99M 600M 232M 2.94B 224M 220M 9.43B

Carmat Stock Other OTC

Stocks

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat

Latest news: Carmat

Analysts' recommendations: Carmat

Press Releases: Carmat

News in other languages: Carmat

Managers and Directors: Carmat

Medical Devices & Implants

Financials

Company Profile